Summary of Significant Accounting Policies (Details) $ in Thousands			3 Months Ended		6 Months Ended		12 Months Ended
	Jan. 01, 2016	Dec. 31, 2015	Jun. 30, 2017 USD ($)	Jun. 30, 2016 USD ($)	Jun. 30, 2017 USD ($) Segment	Jun. 30, 2016 USD ($)	Dec. 31, 2016 USD ($)	Mar. 31, 2016 USD ($)
Summary of Significant Accounting Policies [Line Items]
Provision for inventory obsolescence					$ 4,800	$ 200
Goodwill, in-process research and development and other intangible assets acquired			$ 2,100,000		2,100,000		$ 2,100,000
In-process research and development			645,957		645,957		644,713
Amortization expense			17,953	$ 15,778	35,881	29,221
Intangible assets, net			731,134		731,134		763,976
Depreciation expense					15,400	17,600
Deferred revenue			128,500		128,500		162,400
Revenue from transfer of intellectual property and other			28,576	68,281	47,154	86,898
Allowance for doubtful accounts receivable			55,220		55,220		$ 36,268
Provision for bad debts					50,000	40,500
Equity-based compensation expense					$ 15,844	26,105
Number of reportable segments | Segment					2
Minimum
Summary of Significant Accounting Policies [Line Items]
Intangible assets, estimated useful lives					3 years
Maximum
Summary of Significant Accounting Policies [Line Items]
Intangible assets, estimated useful lives					20 years
Government Contracts Concentration Risk | Sales Revenue, Net
Summary of Significant Accounting Policies [Line Items]
Concentration percentage					26.00%
Government Contracts Concentration Risk | Accounts Receivable
Summary of Significant Accounting Policies [Line Items]
Concentration percentage					20.70%		22.90%
Software
Summary of Significant Accounting Policies [Line Items]
Property, plant and equipment, estimated useful lives					3 years
Machinery, Medical and Other Equipment | Minimum
Summary of Significant Accounting Policies [Line Items]
Property, plant and equipment, estimated useful lives					5 years
Machinery, Medical and Other Equipment | Maximum
Summary of Significant Accounting Policies [Line Items]
Property, plant and equipment, estimated useful lives					8 years
Furniture and Fixtures | Minimum
Summary of Significant Accounting Policies [Line Items]
Property, plant and equipment, estimated useful lives					5 years
Furniture and Fixtures | Maximum
Summary of Significant Accounting Policies [Line Items]
Property, plant and equipment, estimated useful lives					12 years
Buildings and Improvements | Minimum
Summary of Significant Accounting Policies [Line Items]
Property, plant and equipment, estimated useful lives					10 years
Buildings and Improvements | Maximum
Summary of Significant Accounting Policies [Line Items]
Property, plant and equipment, estimated useful lives					40 years
Automobiles and Aircraft | Minimum
Summary of Significant Accounting Policies [Line Items]
Property, plant and equipment, estimated useful lives					3 years
Automobiles and Aircraft | Maximum
Summary of Significant Accounting Policies [Line Items]
Property, plant and equipment, estimated useful lives					15 years
Collaborative Arrangement, Product | Pfizer
Summary of Significant Accounting Policies [Line Items]
Deferred revenue			123,600		$ 123,600
Revenue from transfer of intellectual property and other			$ 17,700	17,700	$ 35,300
Self-Pay | Accounts Receivable
Summary of Significant Accounting Policies [Line Items]
Concentration percentage					6.30%		4.10%
Internal Revenue Service (IRS)
Summary of Significant Accounting Policies [Line Items]
Corporate income tax rate			35.00%		35.00%
Israel Tax Authority
Summary of Significant Accounting Policies [Line Items]
Corporate income tax rate	24.00%	25.00%			23.00%
Scenario, Adjustment
Summary of Significant Accounting Policies [Line Items]
In-process research and development				(187,600)		(187,600)
Intangible assets, net				$ 187,600		$ 187,600
In-process Research and Development
Summary of Significant Accounting Policies [Line Items]
Intangible assets, estimated useful lives						12 years
Rayaldee
Summary of Significant Accounting Policies [Line Items]
Deferred revenue			$ 3,700		$ 3,700
Accounting Standards Update 2016-09, Excess Tax Benefit Component
Summary of Significant Accounting Policies [Line Items]
Deferred tax asset								$ 32,500
Accumulated Deficit | Accounting Standards Update 2016-09, Excess Tax Benefit Component
Summary of Significant Accounting Policies [Line Items]
Cumulative effect of new accounting update								$ (32,500)